A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

OBJECTIVE: To evaluate the clinical utility of the multianalyte assay panel (MAP), commercially known as AVISE Lupus test (Exagen Inc.), in patients suspected of SLE. METHODS: A systematic review of medical records of ANA-positive patients with a positive (>0.1) or negative (<−0.1) MAP score w...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Roberta Vezza, Rey, Daniel Scott, Conklin, John, Domingues, Vinicius, Ahmed, Mansoor, Qureshi, Jazibeh, Weinstein, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276296/
https://www.ncbi.nlm.nih.gov/pubmed/34253650
http://dx.doi.org/10.1136/lupus-2021-000528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276296/
https://www.ncbi.nlm.nih.gov/pubmed/34253650
http://dx.doi.org/10.1136/lupus-2021-000528

Ejemplares similares